An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes

Herold, Kevan C., Bundy, Brian N., Long, S. Alice, Bluestone, Jeffrey A., DiMeglio, Linda A., Dufort, Matthew J., Gitelman, Stephen E., Gottlieb, Peter A., Krischer, Jeffrey P., Linsley, Peter S., Marks, Jennifer B., Moore, Wayne, Moran, Antoinette, Rodriguez, Henry, Russell, William E., Schatz, Desmond, Skyler, Jay S., Tsalikian, Eva, Wherrett, Diane K., Ziegler, Anette-Gabriele, Greenbaum, Carla J.·2019·New England Journal of Medicine
DOI 10.1056/nejmoa1902226

Cited by (1,000)

Items 301–400 of 1,000

  1. Glucagon-receptor-antagonism-mediated β-cell regeneration as an effective anti-diabetic therapy
    Yannan Xi, Benbo Song, Iris Ngan, Mark J. Solloway, Mark Humphrey, Yan Wang, Kalyani Mondal, Hao Wu, Wenhui Liu, Darrin A. Lindhout et al. · 2022 · Cell Reports
  2. The effect of age on longitudinal measures of beta cell function and insulin sensitivity during the progression of early stage type 1 diabetes
    Ele Ferrannini, Andrea Mari, Gabriela S. F. Monaco, Jay S. Skyler, Carmella Evans‐Molina · 2022 · Diabetologia
  3. Predicting Immunological Risk for Stage 1 and Stage 2 Diabetes Using a 1-Week CGM Home Test, Nocturnal Glucose Increments, and Standardized Liquid Mixed Meal Breakfasts, with Classification Enhanced by Machine Learning
    Eslam Montaser, Marc D. Breton, Sue A. Brown, Mark Daniel DeBoer, Boris P. Kovatchev, Leon S. Farhy · 2023 · Diabetes Technology & Therapeutics
  4. Monocytes in type 1 diabetes families exhibit high cytolytic activity and subset abundances that correlate with clinical progression
    Tarun Pant, Chien‐Wei Lin, Amina Bedrat, Shuang Jia, Mark F. Roethle, Nathan A. Truchan, Ashley E. Ciecko, Yi‐Guang Chen, Martin J. Hessner · 2024 · Science Advances
  5. Exploration of Immune Targets for Type 1 Diabetes and Latent Autoimmune Disease Immunotherapy
    Khalid Siddiqui, Shaik Sarfaraz Nawaz · 2023 · ImmunoTargets and Therapy
  6. Inhibition of the eukaryotic initiation factor-2α kinase PERK decreases risk of autoimmune diabetes in mice
    Charanya Muralidharan, Fei Huang, Jacob R. Enriquez, Jiayi E. Wang, Jennifer B. Nelson, Titli Nargis, Sarah C. May, Advaita Chakraborty, Kayla T. Figatner, Svetlana Navitskaya et al. · 2024 · Journal of Clinical Investigation
  7. Screening and care for preclinical stage 1–2 type 1 diabetes in first-degree relatives: French expert position statement
    Roberto Mallone, Élise Bismuth, Charles H. Thivolet, Pierre‐Yves Benhamou, Nadine Hoffmeister, François Collet, Marc P Nicolino, Rachel Reynaud, Jacques Beltrand · 2024 · Diabetes & Metabolism
  8. Leveraging artificial intelligence and machine learning to accelerate discovery of disease-modifying therapies in type 1 diabetes
    Melanie R. Shapiro, Erin M. Tallon, Matthew E. Brown, Amanda L. Posgai, Mark Allen Clements, Todd M. Brusko · 2024 · Diabetologia
  9. Can Celiac Disease Be Prevented?
    Renata Auricchio, Riccardo Troncone · 2021 · Frontiers in Immunology
  10. Etiology of Autoimmune Islet Disease: Timing Is Everything
    Åke Lernmark · 2021 · Diabetes
  11. Antigen-specific immunotherapy to restore antigen-specific tolerance in Type 1 diabetes and Graves’ disease
    Aakansha Zala, Ranjeny Thomas · 2022 · Clinical & Experimental Immunology
  12. Nasal administration of anti-CD3 mAb (Foralumab) downregulates NKG7 and increases TGFB1 and GIMAP7 expression in T cells in subjects with COVID-19
    Thaís Garcias Moreira, Christian D. Gauthier, Liam Murphy, Toby Black Lanser, Anu Paul, Kimble Teixeira Fonseca Matos, Davide Mangani, Saef Izzy, Rafael Machado Rezende, Brian C. Healy et al. · 2023 · Proceedings of the National Academy of Sciences
  13. Prediction of progression to type 1 diabetes with dynamic biomarkers and risk scores
    Mugdha V. Joglekar, Simranjeet Kaur, Flemming Pociot, Anandwardhan A. Hardikar · 2024 · The Lancet Diabetes & Endocrinology
  14. Oral Insulin Delay of Stage 3 Type 1 Diabetes Revisited in HLA DR4-DQ8 Participants in the TrialNet Oral Insulin Prevention Trial (TN07)
    Zhao, Lue Ping, Papadopoulos, George K., Skyler, Jay S., Parikh, Hemang M., Kwok, William W., Bondinas, George P., Moustakas, Antonis K., Wang, Ruihan, Pyo, Chul-Woo, Nelson, Wyatt C. et al. · 2024 · Diabetes Care
  15. Retro-inverso D-peptides as a novel targeted immunotherapy for Type 1 diabetes
    Angela Lombardi, Erlinda Concepcion, Hanxi Hou, Hanane Arib, Mihaly Mezei, Roman Osman, Yaron Tomer · 2020 · Journal of Autoimmunity
  16. Hematopoietic Stem Cells in Type 1 Diabetes
    Ida Pastore, Emma Assi, Moufida Ben Nasr, Andrea Mario Bolla, Anna Maestroni, Vera Usuelli, Cristian Loretelli, Andy Joe Seelam, Ahmed Abdelsalam, Gianvincenzo Zuccotti et al. · 2021 · Frontiers in Immunology
  17. Traveling down the Long Road to Type 1 Diabetes Mellitus Prevention
    Clifford james Rosen, Julie R. Ingelfinger · 2019 · New England Journal of Medicine
  18. Emerging Immunotherapies for Disease Modification of Type 1 Diabetes
    Timothy P. Foster, Brittany Bruggeman, Michael J. Haller · 2025 · Drugs
  19. Type 1 Diabetes TrialNet: Leading the Charge in Disease Prediction, Prevention, and Immunotherapeutic Mechanistic Understanding
    Laura M. Jacobsen, Jamie Lynn Felton, Brandon M. Nathan, Cate Speake, Jeffrey P. Krischer, Kevan C. Herold · 2025 · Diabetes Care
  20. A Comprehensive Review of Novel Advances in Type 1 Diabetes Mellitus
    Yazdan Ebrahimpour, S M Khatami, Mahsa Saffar, Alireza Fereidouni, Zahra Biniaz, Nafiseh Erfanian, Mohammad Fereidouni · 2025 · Journal of Diabetes
  21. Cost Effectiveness of Teplizumab for Prevention of Type 1 Diabetes Among Different Target Patient Groups
    Shweta Mital, Hai V. Nguyen · 2020 · PharmacoEconomics
  22. Lessons from Human Islet Transplantation Inform Stem Cell-Based Approaches in the Treatment of Diabetes
    Taylor M. Triolo, Melena D. Bellin · 2021 · Frontiers in Endocrinology
  23. New Horizons: Emerging Antidiabetic Medications
    Geltrude Mingrone, Lidia Castagneto‐Gissey, Stefan Richard Bornstein · 2022 · The Journal of Clinical Endocrinology & Metabolism
  24. Refining the Definition of Stage 1 Type 1 Diabetes: An Ontology-Driven Analysis of the Heterogeneity of Multiple Islet Autoimmunity
    Brigitte I. Frohnert, Mohamed F. Ghalwash, Ying Li, Kenney Ng, Jessica L. Dunne, Markus Lundgren, William Hagopian, Olivia Lou, Christiane Winkler, Jorma Toppari et al. · 2023 · Diabetes Care
  25. Teplizumab: The First Treatment to Delay the Progression of Type 1 Diabetes
    Jennifer D. Goldman, Hailey Choi · 2023 · Clinical Diabetes
  26. Efficacy of combination therapy with GABA, a DPP-4i and a PPI as an adjunct to insulin therapy in patients with type 1 diabetes
    Alexander Rabinovitch, Daniil Koshelev, Francisco Alejandro Lagunas‐Rangel, Liudmila Kosheleva, Tali Gavra, Helgi B. Schiöth, Shmuel Levit · 2023 · Frontiers in Endocrinology
  27. Pediatric Type 1 Diabetes: Mechanisms and Impact of Technologies on Comorbidities and Life Expectancy
    Flavia Urbano, Ilaria Farella, Giacomina Brunetti, Maria Felicia Faienza · 2023 · International Journal of Molecular Sciences
  28. Predicting the Risk of Developing Type 1 Diabetes Using a One-Week Continuous Glucose Monitoring Home Test With Classification Enhanced by Machine Learning: An Exploratory Study
    Eslam Montaser, Sue A. Brown, Mark Daniel DeBoer, Leon S. Farhy · 2023 · Journal of Diabetes Science and Technology
  29. Reversal of autoimmunity by mixed chimerism enables reactivation of β cells and transdifferentiation of α cells in diabetic NOD mice
    Shanshan Tang, Mingfeng Zhang, Samuel Zeng, Yaxun Huang, Melissa Qin, Ubaydah Nasri, Pere Santamaría, Arthur D. Riggs, Liang Jin, Defu Zeng · 2020 · Proceedings of the National Academy of Sciences
  30. Breaking and restoring immune tolerance to pancreatic beta-cells in type 1 diabetes
    Neslihan Erdem, Enrique Montero, Bart O. Roep · 2021 · Current Opinion in Endocrinology Diabetes and Obesity
  31. Transcending false dichotomies and diagnostic silos to reduce disease burden in mental disorders
    Patrick D. McGorry, Barnaby Nelson, Stephen James Wood, Jai L. Shah, ASHOK K. MALLA, Alison Ruth Yung · 2020 · Social Psychiatry and Psychiatric Epidemiology
  32. Challenges and strategies in clinical applications of CAR-T therapy for autoimmune diseases
    Xiaomei Chen, Kaifan Liu, Bowen Liu, Shiyin Li, Yulian Wang, Xin Du, Jianyu Weng, Bing Song, Kongming Wu, Peilong Lai · 2025 · Journal of Hematology & Oncology
  33. EarLy Surveillance for Autoimmune diabetes: protocol for a qualitative study of general population and stakeholder perspectives on screening for type 1 diabetes in the UK (ELSA 1)
    Lauren Marie Quinn, David Shukla, Sheila Greenfield, Timothy Geoffrey Barrett, Joanna Jane Garstang, Felicity Boardman, Ian J Litchfield, Colin Mark Dayan, Christine Gardner, Clair Connop et al. · 2022 · BMJ Open Diabetes Research & Care
  34. Comparability of C-Peptide Measurements – Current Status and Clinical Relevance
    Sebastian Hörber, Matthias Orth, Andreas Fritsche, Andreas Peter · 2023 · Experimental and Clinical Endocrinology & Diabetes
  35. Hydroxychloroquine in Stage 1 Type 1 Diabetes
    Ingrid M. Libman, Polly J. Bingley, Dorothy J. Becker, Jane Hoyt Buckner, Linda Anne DiMeglio, Stephen Eric Gitelman, Carla J. Greenbaum, Michael J. Haller, Heba M. Ismail, Jeffrey P. Krischer et al. · 2023 · Diabetes Care
  36. Allo Beta Cell transplantation: specific features, unanswered questions, and immunological challenge
    Rossana Caldara, Valentina Tomajer, Paolo Monti, Valeria Sordi, Antonio Citro, Raniero Chimienti, Chiara Gremizzi, Davide Catarinella, Stefano Tentori, Vera Paloschi et al. · 2023 · Frontiers in Immunology
  37. Type 1 Diabetes and Other Autoimmune Disorders in Children
    Eleonora Agata Grasso, Francesco Chiarelli · 2024 · Pediatric Diabetes
  38. The opportunities and challenges of the disease-modifying immunotherapy for type 1 diabetes: A systematic review and meta-analysis
    Chu Lin, Suiyuan Hu, Xiaoling Cai, Fang Lv, Wenjia Yang, Geling Liu, Xiaolin Yang, Linong Ji · 2024 · Pharmacological Research
  39. Young-Onset Diabetes in East Asians: From Epidemiology to Precision Medicine
    Juliana C.N. Chan, Chun Kwan O, Andrea O. Y. Luk · 2024 · Endocrinology and Metabolism
  40. Cracking the type 1 diabetes code: Genes, microbes, immunity, and the early life environment
    Christopher Yau, Jayne S. Danska · 2024 · Immunological Reviews
  41. GABAB-Receptor Agonist-Based Immunotherapy for Type 1 Diabetes in NOD Mice
    Jide Tian, Blake Middleton, Victoria Seunghee Lee, Hye Won Park, Zhixuan Zhang, Bo-Kyoung Kim, Catherine Lowe, Nancy Nguyen, Haoyuan Liu, Ryan S. Beyer et al. · 2021 · Biomedicines
  42. A little help from residual β cells has long-lasting clinical benefits
    Anna P. Lam, Colin Mark Dayan, Kevan C. Herold · 2021 · Journal of Clinical Investigation
  43. Felix dies natalis, insulin… ceterum autem censeo “beta is better”
    Lorenzo Piemonti · 2021 · Acta Diabetologica
  44. Prevention strategies for type 1 diabetes: a story of promising efforts and unmet expectations
    Anna Kanta, Eliza Lyka, Theocharis Koufakis, Pantelis E Zebekakis, Kalliopi Kotsa · 2020 · HORMONES
  45. Trajectory of beta cell function and insulin clearance in stage 2 type 1 diabetes: natural history and response to teplizumab
    Alfonso Galderisi, Emily Kristen Sims, Carmella Evans‐Molina, Alessandra Petrelli, David D Cuthbertson, Brandon M. Nathan, Heba M. Ismail, Kevan C. Herold, Antoinette Moran · 2024 · Diabetologia
  46. The efficacy of islet autoantibody screening with or without genetic pre-screening strategies for the identification of presymptomatic type 1 diabetes
    Ezio E. Bonifacio, Raquel Coelho, Domenik A. Ewald, Gita Gemulla, Michael R. Hubmann, Przemysława A. Jarosz-Chobot, Mirjam Kohls, Olga Kordonouri, Vito Lampasona, Parth Narendran et al. · 2025 · Diabetologia
  47. Teplizumab approval for type 1 diabetes in the USA
    David Beran, Carol Akinyi Abidha, Amanda Adler, Carine E. de Beaufort, Molly Lepeska, Naomi Sharlene Levitt, Elizabeth Pfiester, Jessica Hanae Zafra‐Tanaka, Edwin AM Gale · 2023 · The Lancet Diabetes & Endocrinology
  48. Nanotargeted Delivery of Immune Therapeutics in Type 1 Diabetes
    Sungwook Jung, Moufida Ben Nasr, Baharak Bahmani, Vera Usuelli, Jing Zhao, Gianmarco Sabiu, Andy Joe Seelam, Said Movahedi Naini, Hari Baskar Balasubramanian, Youngrong Park et al. · 2023 · Advanced Materials
  49. Feasibility and Validity of In-Home Self-Collected Capillary Blood Spot Screening for Type 1 Diabetes Risk
    Anna B.E. Sing, Gaetano Naselli, Dexing Huang, Kelly Watson, Peter Grahame Colman, Leonard C. Harrison, John M. Wentworth · 2023 · Diabetes Technology & Therapeutics
  50. Low-Dose Antithymocyte Globulin: A Pragmatic Approach to Treating Stage 2 Type 1 Diabetes
    Timothy P. Foster, Laura M. Jacobsen, Brittany Bruggeman, Chelsea Salmon, Jennifer Hosford, Angela Chen, Miriam Cintrón, Clayton E. Mathews, Clive Henry Wasserfall, Maigan Brusko et al. · 2023 · Diabetes Care
  51. PD-1 Receptor (+) T cells are associated with the efficacy of the combined treatment with regulatory t cells and rituximab in type 1 diabetes children via regulatory t cells suppressive activity amelioration
    Maciej Zieliński, Justyna Sakowska, Dorota Iwaszkiewicz‐Grześ, Mateusz Gliwiński, Matylda Hennig, Magdalena Żalińska, Anna Wołoszyn‐Durkiewicz, Anna Jaźwińska-Curyłło, Halla Kamińska, Radosław Owczuk et al. · 2024 · International Immunopharmacology
  52. A set of circulating microRNAs belonging to the 14q32 chromosome locus identifies two subgroups of individuals with recent-onset type 1 diabetes
    Guido Sebastiani, Giuseppina Emanuela Grieco, Marco Bruttini, Stefano Auddino, Alessia Mori, Mattia Toniolli, Daniela Fignani, Giada Licata, Elena Aiello, Laura Nigi et al. · 2024 · Cell Reports Medicine
  53. First-in-human, double-blind, randomized phase 1b study of peptide immunotherapy IMCY-0098 in new-onset type 1 diabetes: an exploratory analysis of immune biomarkers
    Jean Van Rampelbergh, Peter Achenbach, Richard David Leslie, Martin Kindermans, Frédéric Parmentier, Vincent A. Carlier, Nicolas Bovy, Luc VanderElst, Marcelle Van Mechelen, Pierre Vandepapelière et al. · 2024 · BMC Medicine
  54. Shared and unique immune alterations in pre-clinical autoimmunity
    Samantha R Slight-Webb, Rebecka L. Bourn, Vernon Michael Holers, Judith A. James · 2019 · Current Opinion in Immunology
  55. Prevention of Type 1 Diabetes: Past Experiences and Future Opportunities
    Przemysław Beik, Martyna Ciesielska, Maria Kucza, Alicja Kurczewska, Joanna Kuźmińska, Bartosz Maćkowiak, Elżbieta Niechciał · 2020 · Journal of Clinical Medicine
  56. Current state of antigen-specific immunotherapy for type 1 diabetes
    Frederik Flindt Kreiner, Bernt Johan von Scholten, Ken T. Coppieters, Matthias von Herrath · 2021 · Current Opinion in Endocrinology Diabetes and Obesity
  57. Immune tolerance therapies for autoimmune diseases: Shifting the goalpost to cure
    Patrick Sharkey, Ranjeny Thomas · 2022 · Current Opinion in Pharmacology
  58. Anti-CD3 Antibody Treatment Reduces Scar Formation in a Rat Model of Myocardial Infarction
    Bernhard Wernly, Vera Paar, Achim Michael Aigner, Patrick Michael Pilz, Bruno Karl Podesser, Martin Förster, Christian Jung, Josefina Piñón Hofbauer, Birgit Tockner, Monika Andrea Wimmer et al. · 2020 · Cells
  59. Guidelines for standardizing T-cell cytometry assays to link biomarkers, mechanisms, and disease outcomes in type 1 diabetes
    Yang, Jennie H. M., Ward‐Hartstonge, Kirsten A., Perry, Daniel J., Blanchfield, J. Lori, Posgai, Amanda L., Wiedeman, Alice E., Diggins, Kirsten, Rahman, Adeeb, Tree, Timothy I. M., Brusko, Todd M. et al. · 2022 · European Journal of Immunology
  60. Solving the Puzzle of Immune Tolerance for β-Cell Replacement Therapy for Type 1 Diabetes
    Bluestone, Jeffrey A., Tang, Qizhi · 2020 · Cell Stem Cell
  61. Dysglycaemia definitions and progression to clinical type 1 diabetes in children with multiple islet autoantibodies
    Hummel, Sandra, Koeger, Melanie, Bonifacio, Ezio, Ziegler, Anette-Gabriele · 2025 · The Lancet Diabetes & Endocrinology
  62. The role of oxidative post-translational modifications in type 1 diabetes pathogenesis
    Ghadeer Alhamar, Chiara Vinci, Valentina Franzese, Flavia Tramontana, Nelig Le Goux, Johnny Ludvigsson, Ahuva Nissim, Rocky Strollo · 2025 · Frontiers in Immunology
  63. Addendum. 3. Prevention or Delay of Type 2 Diabetes and Associated Comorbidities: Standards of Care in Diabetes—2023. Diabetes Care 2023;46(Suppl. 1):S41–S48
    Nuha A. ElSayed, Grazia Aleppo, Vanita R. Aroda, Raveendhara R. Bannuru, Florence M. Brown, Dennis Bruemmer, Billy S. Collins, Marisa E. Hilliard, Diana M. Isaacs, Eric L. Johnson et al. · 2023 · Diabetes Care
  64. Combination treatment of a novel CXCR3 antagonist ACT-777991 with an anti-CD3 antibody synergistically increases persistent remission in experimental models of type 1 diabetes
    Urs Christen, Laetitia Pouzol, Mélanie Tunis, Anna Sassi, Camilla Tondello, Monika Bayer, Edith Hintermann, Daniel S. Strasser, Sabrina Schuldes, Ulrich Mentzel et al. · 2023 · Clinical & Experimental Immunology
  65. Delayed graft rejection in autoimmune islet transplantation via biomaterial immunotherapy
    María M. Coronel, Stephen W. Linderman, Karen E. Martin, Michael D. Hunckler, Juan D. Medina, Graham F. Barber, Kayle Riley, Esma S. Yolcu, Haval Shirwan, Andrés J. Garcı́a · 2023 · American Journal of Transplantation
  66. A novel, high-performance, low-volume, rapid luciferase immunoprecipitation system (LIPS) assay to detect autoantibodies to zinc transporter 8
    Claire Louise Williams, Ilaria Marzinotto, Cristina Brigatti, Kathleen M. Gillespie, The BOX Study Group, Isabel S. Wilson, Rachel J. Aitken, Clare Megson, Chitrabhanu Ballav, Atanu Kumar Dutta et al. · 2023 · Clinical & Experimental Immunology
  67. Teplizumab’s immunomodulatory effects on pancreatic β-cell function in type 1 diabetes mellitus
    Emmanuel Kokori, Gbolahan Deji Olatunji, Ikponmwosa Jude Ogieuhi, John Ehi Aboje, Doyin Olatunji, Sikiru Ademola Aremu, Stephen Chukwuemeka Igwe, Abdulrahmon Akanmu Moradeyo, Yusuf Ismaila Ajayi, Nicholas Aderinto · 2024 · Clinical Diabetes and Endocrinology
  68. Factors Associated With the Decline of C-Peptide in a Cohort of Young Children Diagnosed With Type 1 Diabetes
    Andrea K. Steck, Xiang Liu, Jeffrey P. Krischer, Michael J. Haller, Riitta Veijola, Markus Lundgren, Simi T. Ahmed, Beena Akolkar, Jorma Toppari, William Hagopian et al. · 2020 · The Journal of Clinical Endocrinology & Metabolism
  69. The many faces of islet antigen‐specific CD8 T cells: clues to clinical outcome in type 1 diabetes
    ALICE E. WIEDEMAN, Cate Speake, Sarah Alice Long · 2021 · Immunology and Cell Biology
  70. Modeling Type 1 Diabetes Using Pluripotent Stem Cell Technology
    Kriti Joshi, Fergus J. Cameron, Swasti Tiwari, Stuart I. Mannering, Andrew G. Elefanty, Edouard G. Stanley · 2021 · Frontiers in Endocrinology
  71. Toll‐like receptor inflammatory cascade and the development of diabetic kidney disease in children and adolescents with type 1 diabetes
    Thamara R de Melo, Karla S C de Souza, Marcela A G Ururahy, Raul H Bortolin, João F Bezerra, Marcos F de Oliveira Galvão, Rosario D C Hirata, Mario H Hirata, Ricardo F Arrais, Maria das Graças Almeida et al. · 2022 · Journal of Paediatrics and Child Health
  72. Anti-Inflammatory and Pro-Autophagy Effects of the Cannabinoid Receptor CB2R: Possibility of Modulation in Type 1 Diabetes
    Qing‐Rong Liu, Kanikkai Raja Aseer, Qin Yao, Xiaoming Zhong, Paritosh Ghosh, Jennifer F. O’Connell, Josephine Mary Egan · 2022 · Frontiers in Pharmacology
  73. Dysregulation of β-Cell Proliferation in Diabetes: Possibilities of Combination Therapy in the Development of a Comprehensive Treatment
    Natsuki Eguchi, Arvin John Toribio, Michael Alexander, Ivana Xu, David Lee Whaley, Luis F. Hernandez, Donald C. Dafoe, Hirohito Ichii · 2022 · Biomedicines
  74. The CELLO trial: Protocol of a planned phase 4 study to assess the efficacy of Ocrelizumab in patients with radiologically isolated syndrome
    Erin E. Longbrake, Le H. Hua, Ellen M. Mowry, Susan A. Gauthier, Enrique Álvarez, Anne Haney Cross, Jinglan Pei, Jessica Priest, Catarina Raposo, David A. Hafler et al. · 2022 · Multiple Sclerosis and Related Disorders
  75. Biomarkers of autoimmunity and beta cell metabolism in type 1 diabetes
    Meiling Yang, Richard Glenn Kibbey, Mark J. Mamula · 2022 · Frontiers in Immunology
  76. Type 1 Diabetes Genetics Consortium
    Suna Önengüt-Gümüşcü, PATRICK J. CONCANNON, Beena Akolkar, Henry A Erlich, Cécile Julier, Grant Morahan, Concepcion R. Nierras, Flemming Pociot, John A. Todd, Stephen S. Rich · 2025 · The Journal of Clinical Endocrinology & Metabolism
  77. Risk of new‐onset type 1 diabetes in individuals with celiac disease and thyroid disease—An observational study
    Steven V. Edelman, Daniel Agardh, Nancy Cui, Lichen Hao, Mattias Wieloch, Luigi Meneghini · 2025 · Diabetes Obesity and Metabolism
  78. Autoreactive T Cells and Cytokine Stress Drive β-Cell Senescence Entry and Accumulation in Type 1 Diabetes
    Jasmine Pipella, Roozbeh Akbari Motlagh, Nayara Rampazzo Morelli, Peter J. Thompson · 2025 · Diabetes
  79. The Heterogeneity of Type 1 Diabetes: Implications for Pathogenesis, Prevention, and Treatment—2024 Diabetes , Diabetes Care , and Diabetologia Expert Forum
    Carmella Evans‐Molina, Yuval Dor, Åke Lernmark, Chantal Mathieu, Jeffrey R. Millman, Raghavendra G. Mirmira, Flemming Pociot, MARIA JOSE REDONDO, Stephen S. Rich, Sarah J. Richardson et al. · 2025 · Diabetes Care
  80. A year in pharmacology: new drugs approved by the US Food and Drug Administration in 2022
    Gizem Kayki‐Mutlu, Zinnet Şevval Aksoyalp, Leszek Wojnowski, Martin Christian Michel · 2023 · Naunyn-Schmiedeberg s Archives of Pharmacology
  81. Historical Insights and Current Perspectives on the Diagnosis and Management of Presymptomatic Type 1 Diabetes
    Kimber M. Simmons, Brigitte I. Frohnert, Holly K. O’Donnell, KIMBERLY A. BAUTISTA, Cristy Geno Rasmussen, Andrea Gerard Gonzalez, Andrea K. Steck, Marian Rewers · 2023 · Diabetes Technology & Therapeutics
  82. Precise surface functionalization of PLGA particles for human T cell modulation
    Pierce Hadley, Yuanzhou Chen, Lariana Cline, Zhiyuan Han, Qizhi Tang, Xiao Huang, Tejal Ashwin Desai · 2023 · Nature Protocols
  83. Rheumatoid arthritis: prediction of future clinically-apparent disease, and prevention
    Kevin D. Deane · 2024 · Current Opinion in Rheumatology
  84. Abatacept increases T cell exhaustion in early RA individuals who carry HLA risk alleles
    Sarah Alice Long, VIRGINIA S. MUIR, Britta E. Jones, Valerie Wall, Alyssa Ylescupidez, Anne M. Hocking, Stephan Pribitzer, Jerill Thorpe, Bryce Fuchs, ALICE E. WIEDEMAN et al. · 2024 · Frontiers in Immunology
  85. Childhood screening for type 1 diabetes comparing automated multiplex Antibody Detection by Agglutination-PCR (ADAP) with single plex islet autoantibody radiobinding assays
    Alexander Lind, Eva Freyhult, Felipe de Jesus Cortez, Anita Ramelius, Rasmus Bennet, Peter V. Robinson, David Seftel, David Gebhart, Devangkumar Tandel, Marlena Maziarz et al. · 2024 · EBioMedicine
  86. Innovative immunotherapies and emerging treatments in type 1 diabetes management
    Malek Zarei, Mohammad Abbas Sheikholeslami, Masoud Mozaffari, Yassar Mortada · 2024 · Diabetes Epidemiology and Management
  87. Advances in the Pathogenesis and Treatment Strategies for Type 1 Diabetes Mellitus
    Meiheng Du, Sihong Li, Jun Jiang, Xiang Ma, Lu Liu, T. Wang, Jufang Zhang, Dong Niu · 2025 · International Immunopharmacology
  88. Prevention and interception trials in inflammatory bowel disease: an international taskforce assessment on clinical trial design
    Sailish Honap, Nelly Agrinier, Joana Torres, Kenneth Croitoru, Sun-Ho Lee, Williams Turpin, Ryan C. Ungaro, Manasi Agrawal, Inga Peter, Dan Turner et al. · 2025 · The Lancet. Gastroenterology & hepatology
  89. Insulitis in the pancreas of non-diabetic organ donors under age 25 years with multiple circulating autoantibodies against islet cell antigens
    Silke Smeets, Diedert Luc De Paep, Geert M. Stangé, Katrijn Verhaeghen, Bart J.R. Van der Auwera, Bart Keymeulen, Ilse Weets, Zhidong Ling, Pieter In 'T Veld, Frans Gorus · 2021 · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
  90. Transient Depletion of Foxp3+ Regulatory T Cells Selectively Promotes Aggressive β Cell Autoimmunity in Genetically Susceptible DEREG Mice
    Deepika Watts, Marthe Janßen, Mangesh T. Jaykar, Francesco Palmucci, Marc Weigelt, Cathleen Petzold, Angela Hommel, Tim D. Sparwasser, Ezio E. Bonifacio, Karsten Kretschmer · 2021 · Frontiers in Immunology
  91. Four decades of the Bart’s Oxford study: Improved tests to predict type 1 diabetes
    Kathleen M. Gillespie, Rana Fareed, Georgina Mortimer · 2021 · Diabetic Medicine
  92. Self-Antigens Targeted by Regulatory T Cells in Type 1 Diabetes
    Angela M. Mitchell, Aaron W. Michels · 2022 · International Journal of Molecular Sciences
  93. Type 1 diabetes: what is the role of autoimmunity in β cell death?
    Marc Yves Donath · 2022 · Journal of Clinical Investigation
  94. Comparative Analysis of the Sensitivity, Specificity, Concordance, and 5-Year Predictive Power of Diabetes-Related Autoantibody Assays
    Jeffrey P. Krischer, Sarah Müller, Lu You, Peter Achenbach, Elena Bazzigaluppi, Cristina Brigatti, Vito Lampasona, Anu Mathew, Peter V. Robinson, David Seftel et al. · 2025 · Diabetes
  95. Auto-Antikörper-Diagnostik in der Diabetologie – Aktueller Stand der Analytik und klinische Anwendung in Deutschland
    Markus Thaler, Marcel Roos, Astrid Petersmann, Jochen Seißler, Andreas Peter, Rüdiger Landgraf, Ulrich Müller, Dirk Müller‐Wieland, Matthias A. Nauck, Lutz Heinemann et al. · 2022 · Diabetologie und Stoffwechsel
  96. Anti‐CD3 inhibits circulatory and tissue‐resident memory CD4 T cells that drive asthma exacerbations in mice
    Gurupreet Singh Sethi, Donald Tom Gracias, Rinkesh Kumar Gupta, Daniel Carr, Haruka Miki, Ricardo da Silva Antunes, Michael Croft · 2023 · Allergy
  97. Advanced Delivery Strategies for Immunotherapy in Type I Diabetes Mellitus
    Mingshu Huang, Weixing Chen, Min Wang, Yisheng Huang, Hongyu Liu, Yue Ming, Yuanxin Chen, Zhengming Tang, Bo Jia · 2023 · BioDrugs
  98. The amphiregulin/EGFR axis has limited contribution in controlling autoimmune diabetes
    Arielle Raugh, Yi Jing, Matthew L. Bettini, Maria Bettini · 2023 · Scientific Reports
  99. Multifaceted nature of young-onset diabetes - can genomic medicine improve the precision of diagnosis and management?
    Juliana C.N. Chan, Elaine Chow, Alice P.S. Kong, Elaine Y. N. Cheung, O Tony, Cadmon K.P. Lim, Baoqi Fan, Sandra T.F. Tsoi, Yingnan Fan, Mai Shi et al. · 2024 · Journal of Translational Genetics and Genomics
  100. Targeting the TNF/IAP pathway synergizes with anti-CD3 immunotherapy in T-cell acute lymphoblastic leukemia
    Andrea Ávila-Ávila, Kanokporn Nuantang, Mariana L. Oliveira, Sabine Druillennec, Benedetta Zaniboni, Étienne Lengliné, Vahid Asnafi, Jacques Ghysdael, Christine Tran Quang · 2024 · Blood